97 related articles for article (PubMed ID: 2504781)
1. Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.
Levine R; Hoffman JS; Knepple ED; Kenin M
J Clin Psychopharmacol; 1989 Aug; 9(4):281-3. PubMed ID: 2504781
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder.
Frenkel A; Rosenthal J; Nezu A; Winston A
Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952
[TBL] [Abstract][Full Text] [Related]
3. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
Fontaine R; Chouinard G
J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine treatment of obsessive-compulsive disorder.
Turner SM; Jacob RG; Beidel DC; Himmelhoch J
J Clin Psychopharmacol; 1985 Aug; 5(4):207-12. PubMed ID: 3894437
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
Wandzel L
Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
[TBL] [Abstract][Full Text] [Related]
7. Predictors of drug treatment response in obsessive-compulsive disorder.
Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
[TBL] [Abstract][Full Text] [Related]
8. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
Etain B; Bonnet-Perrin E
Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
[TBL] [Abstract][Full Text] [Related]
9. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
Tollefson GD; Birkett M; Koran L; Genduso L
J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
[TBL] [Abstract][Full Text] [Related]
10. Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin.
Eriksson T
Int Clin Psychopharmacol; 2007 Jan; 22(1):57-61. PubMed ID: 17159461
[TBL] [Abstract][Full Text] [Related]
11. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
12. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
Hantouche EG; Bouhassira M; Lancrenon S
Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
Bodfish JW; Madison JT
Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
[TBL] [Abstract][Full Text] [Related]
14. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
[TBL] [Abstract][Full Text] [Related]
15. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
Sevincok L; Topuz A
J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
[TBL] [Abstract][Full Text] [Related]
16. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
[TBL] [Abstract][Full Text] [Related]
17. Individual versus group cognitive behavioral treatment for obsessive-compulsive disorder: follow up.
Jaurrieta N; Jiménez-Murcia S; Alonso P; Granero R; Segalàs C; Labad J; Menchón JM
Psychiatry Clin Neurosci; 2008 Dec; 62(6):697-704. PubMed ID: 19068007
[TBL] [Abstract][Full Text] [Related]
18. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
[TBL] [Abstract][Full Text] [Related]
19. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder.
Jenike MA; Baer L; Buttolph L
J Clin Psychiatry; 1991 Jan; 52(1):13-4. PubMed ID: 1988411
[TBL] [Abstract][Full Text] [Related]
20. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
